Center-Authored Papers

Filters: Author is Masszi, Tamás  [Clear All Filters]
A
Avet-Loiseau H, Fonseca R, Siegel D, Dimopoulos MA, Špička I, Masszi T, Hájek R, Rosiñol L, Goranova-Marinova V, Mihaylov G et al..  2016.  Carfilzomib significantly improves the progression free survival of high-risk patients in multiple myeloma.. Blood. 128(9):1174-1180. Abstract
O
O'Connor OA, Horwitz S, Masszi T, Van Hoof A, Brown P, Doorduijn J, Hess G, Jurczak W, Knoblauch P, Chawla S et al..  2015.  Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results of the Pivotal Phase II BELIEF (CLN-19) Study.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Abstract
S
Stewart KA, Rajkumar VS, Dimopoulos MA, Masszi T, Špička I, Oriol A, Hájek R, Rosiñol L, Siegel DS, Mihaylov GG et al..  2015.  Carfilzomib, lenalidomide, and dexamethasone for relapsed multiple myeloma.. The New England journal of medicine. 372(2):142-52. Abstract